Atomo Diagnostics Ltd (AT1)

Currency in AUD
0.0130
0.0000(0.00%)
Closed·
Earnings results expected today
Trading near 52-week Low
AT1 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.01100.0130
52 wk Range
0.01100.0480
Key Statistics
Bid/Ask
0.011 / 0.013
Prev. Close
0.013
Open
0.012
Day's Range
0.011-0.013
52 wk Range
0.011-0.048
Volume
3.49M
Average Volume (3m)
1.9M
1-Year Change
-53.5714%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AT1 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Atomo Diagnostics Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Atomo Diagnostics Ltd Earnings Call Summary for Q1/2027

  • Atomo Diagnostics Q1 2026 revenue surged 140% YoY to AUD 1.63M, driven by 38% HIV sales growth and 450% jump in OEM revenue from FebriDx partnership.
  • Gross margin fell to 26% from 38% YoY due to product mix shift; EBITDA loss widened to AUD 1.3M as company invests in R&D and manufacturing efficiency.
  • Company ended quarter with AUD 2.67M cash and zero debt; shares unchanged at $0.01, at bottom of 52-week range amid profitability concerns.
  • Gen 4 HIV and syphilis products to begin trials H2 FY2026 with 18-24 month launch timeline; supply deals for brain injury and ferritin products targeted by end 2024.
  • Management expects margin improvement through manufacturing upgrades and higher-margin products in H2; no formal EPS guidance provided but focus remains on scale over near-term profit.
Last Updated: 03-11-2026, 09:00 am
Read Full Transcript

Earnings

Latest Release
30-08-2026
EPS / Forecast
-- / --
Revenue / Forecast
3.15M / --
EPS Revisions
Last 90 days

AT1 Income Statement

Compare AT1 to Peers and Sector

Metrics to compare
AT1
Peers
Sector
Relationship
P/E Ratio
−3.3x−3.3x−0.2x
PEG Ratio
−0.07−0.050.00
Price/Book
1.5x4.1x2.6x
Price / LTM Sales
2.2x3.8x2.7x
Upside (Analyst Target)
-131.7%68.5%
Fair Value Upside
Unlock−7.0%11.5%Unlock

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-testing programs; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
379.02M42.00%4.74M
Public Companies & Retail Investors
523.41M58.00%6.54M
Total
902.43M100.00%11.28M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Gz Family Holdings Pty Ltd11.26%10,15,75,6441,270
Dalraida Holdings Pty Limited7.22%6,51,20,000814

FAQ

What Is the Atomo (AT1) Share Price Today?

The Atomo share price today is 0.0130.

What is the current Atomo (AT1) share price and day range?

As of 18-11-2026, the Atomo share price is 0.0130, with a previous close of 0.0130. The share price has ranged from 0.0110 to 0.0130 today, while the 52-week range spans from 0.0110 to 0.0480.

What Is the Atomo Market Cap?

As of today, Atomo market cap is 11.7300M.

What Is Atomo's Earnings Per Share (TTM)?

The Atomo EPS (TTM) is -0.0042.

When Is the Next Atomo Earnings Date?

Atomo will release its next earnings report on 18-11-2026.

From a Technical Analysis Perspective, Is AT1 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does Atomo Trade On?

Atomo is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Atomo?

The stock symbol for Atomo is "AT1."

How Many Times Has Atomo Stock Split?

Atomo has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.